Company Overview of Global Virus Network
Key Executives for Global Virus Network
Co-Founder and Chair of Scientific Leadership Board
Compensation as of Fiscal Year 2016.
Global Virus Network Key Developments
The Global Virus Network Announces Executive Appointments
Jan 27 16
The Global Virus Network announced the appointment of José Esparza, MD, PhD as President of the company. Dr. Esparza’s appointment will boost company's global impact given his long career in global health, and in particular vaccine development, as evidenced by his successful leadership roles at the Bill & Melinda Gates Foundation. The company also announced the election of Raymond Schinazi, PhD, Hon DSc to company's executive committee. As company's President, Dr. Esparza’s priorities include growing company's funding base by linking governments, businesses, philanthropic organizations and other entities with interest in safeguarding the globe against existing and future viral threats. Dr. Esparza will also harness his expertise in science to initiate and strengthen international collaborations between top researchers in the company as well as to extend the company's reach to important regions of the world. Prior to joining the company as President, from 2004 to 2014 Dr. Esparza was with the Bill & Melinda Gates Foundation, first as Senior Advisor on HIV Vaccines and subsequently as Senior Advisor on Global Health (Vaccines). As a member of company's executive committee, Dr. Schinazi will provide invaluable council to ensure company's varying programs and initiatives continue to grow and succeed. Dr. Schinazi, who holds more than 90 issued U.S. and international patents.
Global Virus Network Announces Executive Changes
Jan 8 15
The Global Virus Network announced the election of finance and business leader N. Scott Fine as Chairman of the Board of Directors. Mr. Fine succeeds the outgoing Board Chairman, attorney Timothy C. Moynahan, who will take on a new role as Board Vice Chairman. In 2014, Mr. Fine was appointed Chairman of the Board of Directors of CTD Holdings Inc.
The Global Virus Network Announces Executive Changes
Jan 8 15
The Global Virus Network announced the election of Azad Moopen to it's board of directors. Dr. Moopen is an innovator in expanding access to healthcare. Dr. Azad Moopen is the chairman and managing director of Aster DM Healthcare. Joining GVN as a senior sdvisor is MV Pillai, MD, professor of Oncology at Thomas Jefferson University, Philadelphia and chairman of Oncology at Aster MedCity, among his other leadership roles.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries